WO2009021150A2
|
|
Platelet derived growth factor receptor supports cytomegalovirus infectivity
|
WO2008154532A1
|
|
Method and kit for dynamic gene expression monitoring
|
CN101772581A
|
|
Method to predict or diagnose a gastrointestinal disorder or disease
|
WO2008144475A1
|
|
Methods and compositions for treating cancer
|
EP1946007A2
|
|
Anbrosteeone derivatives and method of use thereof
|
WO2007041397A2
|
|
Targeted pharmaceuticals and ligands
|
WO2006138717A2
|
|
Methods and apparatus for determining proportions of body materials
|
WO2006034227A2
|
|
Face mask
|
US2005014165A1
|
|
Biomarker panel for colorectal cancer
|
US7342114B2
|
|
Podophyllotoxin derivatives
|
WO03101998A1
|
|
Nitrogen-based homo-camptothecin derivatives
|
AU2003243397A1
|
|
Homo-camptothecin derivatives
|
US6825236B2
|
|
Colchicine derivatives
|
US6855720B2
|
|
Nitrogen-based camptothecin derivatives
|
US7056663B2
|
|
Prognostic methods for breast cancer
|
US6403604B1
|
|
Nitrogen-based camptothecin derivatives
|
US6350756B1
|
|
Camptothecin derivatives
|
WO0157061A1
|
|
Novel use of ribozymes to block gene expression
|
US6423707B1
|
|
Nitroimidazole ester analogues and therapeutic applications
|
AU5474899A
|
|
Genes amplified in cancer cells
|